ArticleBMJ open2023

Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta.

Jannie D Hald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.